The Italian OPERA experiment is reporting that neutrinos can break the cosmic speed limit, the speed of light. But science advances by skepticism, inquiry, and questioning everything—even new results.
Investors from China visited TRIUMF, interested in the leading accelerator technology and the production and application of medical isotopes of our lab.
AAPS and several Vancouver partners have launched IKOMED Technologies, Inc., to develop and deploy new technology for reducing radiation exposure during medical fluoroscopy procedures.
Heroic efforts make the commissioning of Beam Line 1A after extensive repairs and the refurbishing of Target Module 1 very successful. Congratulations to the hard-working teams!
Apart from helping keep TRIUMF safe, the Manager of the QA & Training division, Phil Jones, is working to develop guidelines for nuclear facilities across Canada.